Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Bioorganic & Medicinal Chemistry
|
March 1, 2011
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors
Kunal Nepali, Gurinderdeep Singh, Anil Turan, et al.
European Journal of Medicinal Chemistry
|
July 20, 2022
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier
Ram Sharma, Esha Chatterjee, Jacob Mathew, et al.
Organic & Biomolecular Chemistry
|
December 24, 2015
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
Kunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Organic & Biomolecular Chemistry
|
June 16, 2018
Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
Kunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
European Journal of Medicinal Chemistry
|
March 24, 2018
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC
Ritu Ojha, Han-Li Huang, Wei-Chun HuangFu, et al.
Journal of Medicinal Chemistry
|
January 29, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity <i>In Vitro</i> and <i>In Vivo</i>
Sachin Sharma, Shao-An Wang, Wen-Bin Yang, et al.
Frontiers in Pharmacology
|
June 20, 2025
Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo
Essha Chatterjee, Ram Sharma, Biswajit Dey, et al.
Bioorganic Chemistry
|
October 7, 2025
Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation
Mandeep Rana, N VijayKamasewara Rao, Zih-Yao Yu, et al.
European Journal of Medicinal Chemistry
|
November 27, 2018
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
Mei-Jung Lai, Ritu Ojha, Mei-Hsiang Lin, et al.
European Journal of Medicinal Chemistry
|
December 16, 2019
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment
Navdeep Kaur, Yao-Ching Fang, Hsueh-Yun Lee, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Bioorganic & Medicinal Chemistry
|
March 1, 2011
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors
Kunal Nepali, Gurinderdeep Singh, Anil Turan, et al.
European Journal of Medicinal Chemistry
|
July 20, 2022
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier
Ram Sharma, Esha Chatterjee, Jacob Mathew, et al.
Organic & Biomolecular Chemistry
|
December 24, 2015
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
Kunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Organic & Biomolecular Chemistry
|
June 16, 2018
Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
Kunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
European Journal of Medicinal Chemistry
|
March 24, 2018
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC
Ritu Ojha, Han-Li Huang, Wei-Chun HuangFu, et al.
Journal of Medicinal Chemistry
|
January 29, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity <i>In Vitro</i> and <i>In Vivo</i>
Sachin Sharma, Shao-An Wang, Wen-Bin Yang, et al.
Frontiers in Pharmacology
|
June 20, 2025
Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo
Essha Chatterjee, Ram Sharma, Biswajit Dey, et al.
Bioorganic Chemistry
|
October 7, 2025
Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation
Mandeep Rana, N VijayKamasewara Rao, Zih-Yao Yu, et al.
European Journal of Medicinal Chemistry
|
November 27, 2018
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
Mei-Jung Lai, Ritu Ojha, Mei-Hsiang Lin, et al.
European Journal of Medicinal Chemistry
|
December 16, 2019
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment
Navdeep Kaur, Yao-Ching Fang, Hsueh-Yun Lee, et al.
Page
of 9